Streetbeat News

Products Services

VWAGY

The Polish Ministry of Health supports decriminalizing cannabis possession and cultivation, reflecting growing public support. However, political challenges remain, with potential presidential vetoes and conservative parliamentary opposition. The cannabis industry in Poland is gaining momentum, with local hemp varieties showing promise.

Portfolio Pulse from Nina Zdinjak

September 06, 2024 | 6:10 pm

DV

META

DoubleVerify Holdings, Inc. (NYSE:DV) has launched a new Inflammatory Politics and News category on Meta Platforms, Inc. (NASDAQ:META), allowing advertisers to verify campaign quality against controversial content. Despite this launch, DV shares are trading lower, continuing a year-long decline.

Portfolio Pulse from Nabaparna Bhattacharya

September 06, 2024 | 6:08 pm

BNTX

BVNKF

MRNA

Moderna's investigational mpox vaccine, mRNA-1769, shows greater effectiveness than the current Jynneos vaccine in animal studies. The vaccine is in Phase 1/2 trials, with results expected in 2025. BioNTech is also developing a similar vaccine. Moderna's stock is down 1.39%.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 6:02 pm

MCD

Investors are showing a bullish stance on McDonald's (NYSE:MCD) through options trading, with a significant number of call options being purchased. The price range targeted by these trades is between $280 and $305. Analysts have set a price target of $340, with some maintaining a Buy rating. McDonald's stock is currently trading at $291.52, up by 1.23%.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 6:02 pm

AVGO

Analysts are optimistic about Broadcom Inc's (NASDAQ:AVGO) long-term potential, particularly its AI franchise, despite a recent dip in stock price. Multiple analysts have reiterated buy or overweight ratings, citing strong AI and VMWare performance. However, some noted that the recent earnings report did not meet all expectations.

Portfolio Pulse from Chris Katje

September 06, 2024 | 5:54 pm

BCYC

PFE

RBC Capital initiated coverage on Bicycle Therapeutics (BCYC) with an Outperform rating, highlighting its lead cancer candidate Zelenectide's potential in oncology. The drug shows promise in metastatic urothelial cancer with fewer adverse events compared to Pfizer's Padcev. RBC sees a $2 billion peak sales potential by 2033 and notes additional opportunities in other solid tumors. Bicycle's strong pipeline and financial position further support its growth prospects.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 5:37 pm

AMZN

ANF

BABA

ETSY

H

PDD

RIVN

TSLA

TXRH

VFS

The article highlights unusual options activity in the Consumer Discretionary sector, focusing on large trades by 'whales' in companies like TSLA, AMZN, BABA, PDD, RIVN, VFS, H, ETSY, ANF, and TXRH. These trades indicate varying market sentiments, with some bullish and others bearish.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 5:35 pm

RBLX

Roblox has announced that it will increase the revenue share for developers of paid access experiences, allowing up to 70% of the revenue to go to the developers. This move is likely aimed at attracting more developers to the platform and enhancing the quality of content available to users.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 5:32 pm

RBLX

Roblox is introducing a new feature that allows developers to price paid access experiences in real currency on desktop platforms. This move could potentially increase revenue streams for developers and enhance the platform's monetization capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 5:31 pm

RBLX

SHOP

Roblox has announced a partnership with Shopify and plans to integrate with various e-commerce platforms, as revealed at the Developers Conference.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 5:29 pm